trial · primary record
Busulfan
SCID
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 56 |
| Primary completion | 2028-12-01 |
| Primary endpoint | Vaccine specific antibody response |
| Registry ID | NCT03619551 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:30.448Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03619551
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.